{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:53:03Z","timestamp":1761864783400,"version":"3.44.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,9]]},"DOI":"10.7759\/cureus.91887","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:11:15Z","timestamp":1757409075000},"source":"Crossref","is-referenced-by-count":1,"title":["Conjunctival Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Associated With Methotrexate Therapy: A Case of Complete Remission Following Drug Discontinuation"],"prefix":"10.7759","author":[{"given":"Kazuyuki","family":"Shimada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minori","family":"Minamide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihide","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Sotozono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12116","article-title":"Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression","volume":"91","author":"Ichikawa A","year":"2013","unstructured":"Ichikawa A, Arakawa F, Kiyasu J, et al.. Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol. 2013, 91:20-8. 10.1111\/ejh.12116","journal-title":"Eur J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13249","article-title":"Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types","volume":"108","author":"Gion Y","year":"2017","unstructured":"Gion Y, Iwaki N, Takata K, et al.. Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types. Cancer Sci. 2017, 108:1271-80. 10.1111\/cas.13249","journal-title":"Cancer Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh313","article-title":"Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas","volume":"96","author":"Feng WH","year":"2004","unstructured":"Feng WH, Cohen JI, Fischer S, et al.. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst. 2004, 96:1691-702. 10.1093\/jnci\/djh313","journal-title":"J Natl Cancer Inst"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-016-0439-z","article-title":"Methotrexate-associated orbital lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report","volume":"60","author":"Kobayashi Y","year":"2016","unstructured":"Kobayashi Y, Kimura K, Fujitsu Y, Shinkawa K, Muta H, Sonoda KH. Methotrexate-associated orbital lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report. Jpn J Ophthalmol. 2016, 60:212-8. 10.1007\/s10384-016-0439-z","journal-title":"Jpn J Ophthalmol"},{"key":"ref5","article-title":"Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sj\u00f6gren's syndrome: case series","volume":"28","author":"Dawson TM","year":"2001","unstructured":"Dawson TM, Starkebaum G, Wood BL, Willkens RF, Gown AM. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sj\u00f6gren's syndrome: case series. J Rheumatol. 2001, 28:47-53.","journal-title":"J Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1022769","article-title":"Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal","volume":"56","author":"Inui Y","year":"2015","unstructured":"Inui Y, Matsuoka H, Yakushijin K, et al.. Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal. Leuk Lymphoma. 2015, 56:3045-51. 10.3109\/10428194.2015.1022769","journal-title":"Leuk Lymphoma"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3764-8","article-title":"Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regression","volume":"37","author":"Takanashi S","year":"2017","unstructured":"Takanashi S, Aisa Y, Ito C, et al.. Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regression. Rheumatol Int. 2017, 37:1629-33. 10.1007\/s00296-017-3764-8","journal-title":"Rheumatol Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/art.20311","article-title":"Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients","volume":"50","author":"Wolfe F","year":"2004","unstructured":"Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum. 2004, 50:1740-51. 10.1002\/art.20311","journal-title":"Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2009.131","article-title":"Immunomodulator agent-related lymphoproliferative disorders","volume":"22","author":"Hasserjian RP","year":"2009","unstructured":"Hasserjian RP, Chen S, Perkins SL, et al.. Immunomodulator agent-related lymphoproliferative disorders. Mod Pathol. 2009, 22:1532-40. 10.1038\/modpathol.2009.131","journal-title":"Mod Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0264-2","article-title":"Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases","volume":"32","author":"Satou A","year":"2019","unstructured":"Satou A, Tabata T, Miyoshi H, et al.. Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases. Mod Pathol. 2019, 32:1135-46. 10.1038\/s41379-019-0264-2","journal-title":"Mod Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/397139-conjunctival-mucosa-associated-lymphoid-tissue-malt-lymphoma-associated-with-methotrexate-therapy-a-case-of-complete-remission-following-drug-discontinuation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:11:22Z","timestamp":1757409082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/397139-conjunctival-mucosa-associated-lymphoid-tissue-malt-lymphoma-associated-with-methotrexate-therapy-a-case-of-complete-remission-following-drug-discontinuation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.91887","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,9]]}}}